These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 7145555)
1. Potential for single high-dose influenza immunization in unprimed children. Gross PA; Quinnan GV; Gaerlan PF; Denning CR; Davis A; Lazicki M; Bernius M Pediatrics; 1982 Dec; 70(6):982-6. PubMed ID: 7145555 [TBL] [Abstract][Full Text] [Related]
2. Influenza vaccines in children. Comparison of new cetrimonium bromide and standard ether-treated vaccines. Gross PA; Quinnan GV; Gaerlan PF; Denning CR; Lazicki M; Bernius M Am J Dis Child; 1983 Jan; 137(1):26-8. PubMed ID: 6847954 [TBL] [Abstract][Full Text] [Related]
3. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Englund JA; Walter EB; Fairchok MP; Monto AS; Neuzil KM Pediatrics; 2005 Apr; 115(4):1039-47. PubMed ID: 15805382 [TBL] [Abstract][Full Text] [Related]
4. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines. Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD Am J Dis Child; 1982 Jun; 136(6):513-7. PubMed ID: 7046421 [TBL] [Abstract][Full Text] [Related]
6. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
7. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months. Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD Pediatrics; 1982 Apr; 69(4):404-8. PubMed ID: 7070886 [TBL] [Abstract][Full Text] [Related]
8. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine]. Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use. Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505 [TBL] [Abstract][Full Text] [Related]
10. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951 [TBL] [Abstract][Full Text] [Related]
11. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines. Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361 [TBL] [Abstract][Full Text] [Related]
12. Specific antibody response after influenza immunization in systemic lupus erythematosus. Abu-Shakra M; Press J; Varsano N; Levy V; Mendelson E; Sukenik S; Buskila D J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151 [TBL] [Abstract][Full Text] [Related]
14. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. Goji NA; Nolan C; Hill H; Wolff M; Noah DL; Williams TB; Rowe T; Treanor JJ J Infect Dis; 2008 Sep; 198(5):635-41. PubMed ID: 18694338 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318 [TBL] [Abstract][Full Text] [Related]
16. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors. Bektas O; Karadeniz C; Oguz A; Berberoglu S; Yilmaz N; Citak C Pediatr Blood Cancer; 2007 Dec; 49(7):914-7. PubMed ID: 17262793 [TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults. Langley JM; Halperin SA; McNeil S; Smith B; Jones T; Burt D; Mallett CP; Lowell GH; Fries L Vaccine; 2006 Mar; 24(10):1601-8. PubMed ID: 16303215 [TBL] [Abstract][Full Text] [Related]